Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) just unveiled an update.
Charmacy Pharmaceutical Co., Ltd. has announced that its board of directors will hold a meeting on March 28, 2025, to consider and approve the company’s annual results for the year ended December 31, 2024. The meeting will also discuss the recommendation for the payment of a final dividend, if applicable. This announcement signifies a critical step in the company’s financial reporting and potential dividend distribution, which could impact investor sentiment and the company’s market positioning.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products.
YTD Price Performance: -20.61%
Average Trading Volume: 4,805
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$840.2M
See more insights into 2289 stock on TipRanks’ Stock Analysis page.